Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In this study, we defined the role of peroxisome proliferator-activated receptor β/δ (PPARδ) in metabolic homeostasis by using subtype selective agonists. Analysis of rat L6 myotubes treated with the PPARδ subtype-selective agonist, GW501516, by the Affymetrix oligonucleotide microarrays revealed that PPARδ controls fatty acid oxidation by regulating genes involved in fatty acid transport, β-oxidation, and mitochondrial respiration. Similar PPARδ-mediated gene activation was observed in the skeletal muscle of GW501516-treated mice. Accordingly, GW501516 treatment induced fatty acid β-oxidation in L6 myotubes as well as in mouse skeletal muscles. Administration of GW501516 to mice fed a high-fat diet ameliorated diet-induced obesity and insulin resistance, an effect accompanied by enhanced metabolic rate and fatty acid β-oxidation, proliferation of mitochondria, and a marked reduction of lipid droplets in skeletal muscles. Despite a modest body weight change relative to vehicle-treated mice, GW501516 treatment also markedly improved diabetes as revealed by the decrease in plasma glucose and blood insulin levels in genetically obese ob / ob mice. These data suggest that PPARδ is pivotal to control the program for fatty acid oxidation in the skeletal muscle, thereby ameliorating obesity and insulin resistance through its activation in obese animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, SIRT1 activators like resveratrol and NAD+ precursors have been shown to enhance mitochondrial biogenesis and oxidative metabolism, leading to improved muscle function and recovery”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, PPAR agonists, such as pioglitazone (PPAR-γ) and the investigational GW501516 (PPAR-δ), have been shown in clinical and preclinical studies to enhance lipid metabolism and insulin sensitivity”
From Exercise-Induced Muscle–Fat Crosstalk: Molecular Mediators and Their Pharmacological Modulation for the Maintenance of Metabolic Flexibility in Aging (2025) · cites this paper as [112]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Treating mice with PPARα or PPARβ/δ agonists also induces, either directly or indirectly, an increase in whole body oxygen consumption without affecting caloric intake, thus accounting for lower rates of weight gain in response to high fat feeding (Guerre-Millo et al., 2000; Tanaka et al., 2003).”
From Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle (2012) · cites this paper as Tanaka et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
Forman, B. M., Chen, J., & Evans, R. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4312 · Cited by 2,116
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766
Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity
Wang, Y.-X., Lee, C.-H., Tiep, S., Yu, R. T., Ham, J., Kang, H., & Evans, R. M. (2003) · Cell · doi:10.1016/s0092-8674(03)00269-1 · Cited by 1,296
Research works printed but not linked: 1
- Dressel, U., Allen, T. L., Pippal, J. B., Rohde, P. R., Lau, P. & Muscat, G. E. (2003) Mol Endocrinol., in press. [DOI] [PubMed]
Cited by
Items 501–600 of 860
Miyachi, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179223 · Cited by 22
Lundell, K., Thulin, P., Hamsten, A., & Ehrenborg, E. (2007) · BMC Molecular Biology · doi:10.1186/1471-2199-8-70 · Cited by 27
Bell, E. L., Shine, R. W., Dwyer, P., Olson, L., Truong, J. K., Fredenburg, R. A., Goddeeris, M. M., Stickens, D., & Tozzo, E. (2018) · Mitochondrion · doi:10.1016/j.mito.2018.02.006 · Cited by 24
Jeng, J.-Y., Yeh, T.-S., Chiu, Y.-H., Lee, Y., Cheng, H.-H., & Hsieh, R. (2009) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.80684 · Cited by 24
PPARD haplotype influences cholesterol metabolism but is no risk factor of Alzheimer's disease
Holzapfel, J., Heun, R., Lütjohann, D., Jessen, F., Maier, W., & Kölsch, H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.029 · Cited by 22
A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome
Auinger, A., Rubin, D., Sabandal, M. M. I., Helwig, U., Rüther, A., Schreiber, S., Fölsch, U. R., Döring, F., & Schrezenmeir, J. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512002656 · Cited by 23
Kim, J., Wellmann, K. B., Smith, Z. K. F., & Johnson, B. J. (2018) · Journal of Animal Science · doi:10.1093/jas/sky155 · Cited by 25
Leptin, Acting at Central Level, Increases FGF21 Expression in White Adipose Tissue via PPARβ/δ
Mazuecos, L., Pintado, C., Rubio, B., Guisantes-Batán, E., Andrés, A., & Gallardo, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094624 · Cited by 22
Fan, L., Sweet, D. R., Fan, E., Prosdocimo, D. A., Madera, A., Jiang, Z., Padmanabhan, R., Haldar, S. M., Vinayachandran, V., & Jain, M. K. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101926 · Cited by 24
Kim, E., Kim, E. J., Seo, S.-W., Hur, C., McGregor, R. A., & Choi, M. (2013) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.619283 · Cited by 24
Cresser, J., Bonen, A., Chabowski, A., Stefanyk, L. E., Gulli, R. A., Ritchie, I. R. W., & Dyck, D. J. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00431.2009 · Cited by 26
Liang, Y., Chen, S.-A., & Jian, J.-H. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.03.011 · Cited by 22
Min, L., Yanase, T., Tanaka, T., Fan, W., Nomura, M., Kawate, H., Okabe, T., Takayanagi, R., & Nawata, H. (2009) · Endocrinology · doi:10.1210/en.2009-0405 · Cited by 23
Self-citationRoles of peroxisome proliferator-activated receptor ?? in skeletal muscle function and adaptation
Fredenrich, A., & Grimaldi, P. A. (2004) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000134370.93686.0a · Cited by 28
Activation of PPAR δ: from computer modelling to biological effects
Kahremany, S., Livne, A., Gruzman, A., Senderowitz, H., & Sasson, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12950 · Cited by 24
Mosti, M. P., Stunes, A. K., Ericsson, M., Pullisaar, H., Reseland, J. E., Shabestari, M. G., Eriksen, E. F., & Syversen, U. (2014) · Endocrinology · doi:10.1210/en.2013-1166 · Cited by 23
Fang, X., Li, F., Liu, A., Wang, X., Zhao, B., & Wang, N. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13160 · Cited by 22
Rationally designed PPARδ-specific agonists and their therapeutic potential for metabolic syndrome
Cox, R. L. (2017) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1702084114 · Cited by 20
Saturated fatty acid attenuates anti-obesity effect of green tea
Yamashita, S., Hirashima, A., Lin, I.-C., Bae, J., Nakahara, K., Murata, M., Yamada, S., Kumazoe, M., Yoshitomi, R., Kadomatsu, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28338-5 · Cited by 22
Manio, M. C. C., Matsumura, S., Masuda, D., & Inoue, K. (2017) · Physiological Reports · doi:10.14814/phy2.13282 · Cited by 19
Nuclear Hormone Receptor Modulators for the Treatment of Diabetes and Dyslipidemia
Meinke, P. T., Wood, H. B., & Szewczyk, J. W. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41006-x · Cited by 21
Malik, A., Nadeem, M., & Malik, M. I. (2021) · Clinical Journal of Gastroenterology · doi:10.1007/s12328-021-01491-7 · Cited by 22
D’Aniello, E., Amodeo, P., & Vitale, R. M. (2023) · Marine Drugs · doi:10.3390/md21020089 · Cited by 26
Park, S., Cha, H.-N., Shin, M., Park, S., Kim, Y., Kim, M., Shin, K., Thoudam, T., Lee, E. J., Wolfe, R. R., et al. (2024) · Diabetes · doi:10.2337/db23-0432 · Cited by 20
Vascular effects of PPARγ activators – From bench to bedside
Marx, N., & Walcher, D. (2007) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.05.003 · Cited by 22
Jiang, L., Wan, J., Ke, L., Lü, Q., & Tong, N. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0520-8 · Cited by 21
Minegishi, Y., Haramizu, S., Misawa, K., Shimotoyodome, A., Hase, T., & Murase, T. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00071.2015 · Cited by 19
Heitel, P., Faudone, G., Helmstädter, M., Schmidt, J., Kaiser, A., Tjaden, A., Schröder, M., Müller, S., Schierle, S., Pollinger, J. C., et al. (2020) · Communications Chemistry · doi:10.1038/s42004-020-00411-z · Cited by 21
HSF-1 promotes longevity through ubiquilin-1-dependent mitochondrial network remodelling
Erinjeri, A. P., Wang, X., Williams, R., Chiozzi, R. Z., Thalassinos, K., & Labbadia, J. P. (2024) · Nature Communications · doi:10.1038/s41467-024-54136-x · Cited by 24
A Photohormone for Light-Dependent Control of PPARα in Live Cells
Willems, S., Morstein, J., Hinnah, K., Trauner, D. H., & Merk, D. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00810 · Cited by 19
Tůmová, J., Mališová, L., Anděl, M., & Trnka, J. (2015) · Lipids · doi:10.1007/s11745-015-4058-0 · Cited by 20
Pérez‐Schindler, J., Svensson, K., Vargas‐Fernández, E., Santos, G., Wahli, W., & Handschin, C. (2014) · Diabetologia · doi:10.1007/s00125-014-3352-3 · Cited by 19
Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions
Mine, Y., Miyashita, K., & Shahidi, F. (2009) · Wiley eBooks · doi:10.1002/9780813807263 · Cited by 22
Coleman, J. L., Carrigan, C. T., & Margolis, L. M. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00440-6 · Cited by 13
Takagi, H., Ikehara, T., Kashiwagi, Y., Hashimoto, K., Nanchi, I., Shimazaki, A., Nambu, H., & Yukioka, H. (2018) · Endocrinology · doi:10.1210/en.2018-00338 · Cited by 19
Fabiani, E. D., Mitro, N., Godio, C., Gilardi, F., Caruso, D., & Crestani, M. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.027 · Cited by 19
Pleiotropic Effects of Peroxisome Proliferator-Activated Receptor γ and δ in Vascular Diseases
Cheang, W. S., Fang, X., & Tian, X. Y. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0647 · Cited by 19
Mizunoya, W., Iwamoto, Y., Sato, Y., Tatsumi, R., & Ikeuchi, Y. (2013) · Animal Science Journal · doi:10.1111/asj.12143 · Cited by 23
Oxidative and anti-oxidative status in muscle of young rats in response to six protein diets
Zhu, J. K., Xiao, L., Qi, H., Gu, Z., Song, S., Yang, X., Zhou, G., & Li, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-11834-5 · Cited by 18
Telmisartan is effective to ameliorate metabolic syndrome in rat model – a preclinical report
Cheng, K., Li, Y., Chang, W., Kuo, F. Y., Chen, Z., & Cheng, J. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s187092 · Cited by 19
miR-183 and miR-96 orchestrate both glucose and fat utilization in skeletal muscle
Wang, H., Ma, M., Li, Y., Liu, J., Sun, C., Liu, S., Ma, Y., Yan, Y., Tang, Z., Shen, S., et al. (2021) · EMBO Reports · doi:10.15252/embr.202052247 · Cited by 17
Design of a partial PPARδ agonist
Pettersson, I., Ebdrup, S., Havránek, M., Pihera, P., Kořínek, M., Mogensen, J. P., Jeppesen, C. B., Johansson, E., & Sauerberg, P. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.079 · Cited by 17
Meidtner, K., Schwarzenbacher, H., Scharfe, M., Severitt, S., Blöcker, H., & Fries, R. (2009) · BMC Genetics · doi:10.1186/1471-2156-10-76 · Cited by 17
Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?
Vatish, M., Yamada, E., Pessin, J. E., & Bastie, C. C. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450903164348 · Cited by 21
Guo, J., Lu, W., Liang, S., Choi, J., Kim, N., & Cui, X.-S. (2016) · Theriogenology · doi:10.1016/j.theriogenology.2016.11.018 · Cited by 18
The Treatment of Dyslipidemia—What's Left in the Pipeline?
Rau, O., Zettl, H., Popescu, L. N., Steinhilber, D., & Schubert‐Zsilavecz, M. (2008) · ChemMedChem · doi:10.1002/cmdc.200700165 · Cited by 21
Miyawaki, K., Inoue, H., Keshavarz, P., Mizuta, K., Sato, A., Sakamoto, Y., Moritani, M., Kunika, K., Tanahashi, T., & Itakura, M. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.06.014 · Cited by 19
Pedraza, N., Rosell, M., Villarroya, J., Iglesias, R., Gonzalez, F. J., Solanes, G., & Villarroya, F. (2006) · Endocrinology · doi:10.1210/en.2006-0226 · Cited by 20
Double gene deletion reveals the lack of cooperation between PPARα and PPARβ in skeletal muscle
Bedu, E., Dominique Desplanches, C., Pequignot, J., Bordier, B., & Desvergne, B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.003 · Cited by 22
The Transcription Factor B-Cell Lymphoma (BCL)-6 Modulates Pancreatic β-Cell Inflammatory Responses
Igoillo‐Esteve, M., Gurzov, E. N., Eizirik, D. L., & Cnop, M. (2010) · Endocrinology · doi:10.1210/en.2010-0790 · Cited by 18
Ren, Q., Deng, L., Zhou, Z., Wang, X., Hu, L., Xie, R., & Li, Z. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103963 · Cited by 17
Barrett, J. S., Whytock, K. L., Strauss, J. A., Wagenmakers, A. J. M., & Shepherd, S. O. (2022) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0631 · Cited by 18
Takahashi, H., Yang, G., Yoneshiro, T., Abe, Y., Ito, R., Yang, C., Nakazono, J., Okamoto-Katsuyama, M., Uchida, A., Arai, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33363-0 · Cited by 19
Self-citationElafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ
Zhang, M., Barroso, E., Ruart, M., Peña, L., Peyman, M., Aguilar-Recarte, D., Montori-Grau, M., Rada, P., Cugat, C., Montironi, C., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115623 · Cited by 18
Pan, H.-C., Yang, C.-N., Lee, W., Sheehan, J. P., Wu, S., Chen, H.-S., Lin, M.-H., Shen, L., Lee, S.-H., Shen, C.-C., et al. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10108-y · Cited by 18
Peroxisome Proliferator-Activated Receptors (PPARs) in Glucose Control
Chiazza, F., & Collino, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00009-9 · Cited by 22
Leońska‐Duniec, A., Cięszczyk, P., Jastrzębski, Z., Jażdżewska, A., Lulińska–Kuklik, E., Moska, W., Ficek, K., Niewczas, M., & Maciejewska, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202557 · Cited by 17
Proteomics study of the effect of high-fat diet on rat liver
Sang, J., Qu, H., Gu, R., Chen, D., Chen, X., Yin, B., Huang, Y., Xi, W., Wang, C., & Huang, Y. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001740 · Cited by 15
Koh, J., Kim, K., Park, S.-Y., Kim, Y., & Kim, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00749 · Cited by 17
Xiang, L., Nie, J., Wang, L., Wang, Y., Shi, J., Wei, J., Lau, C., Cai, Z., & Huang, Y. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.12.042 · Cited by 16
Sakuma, S., Endo, T., Kanda, T., Nakamura, H., Yamasaki, S., & Yamakawa, T. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.11.030 · Cited by 17
Shimizu, M., Akter, M. H., Emi, Y., Sato, R., Yamaguchi, T., Hirose, F., & Osumi, T. (2006) · The Journal of Biochemistry · doi:10.1093/jb/mvj053 · Cited by 16
Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
Zhang, L., Wang, S., Xu, W., Wang, R., & Wang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048453 · Cited by 17
Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
d’Angelo, M., Castelli, V., Tupone, M. G., Catanesi, M., Antonosante, A., Dominguez-Benot, R., Ippoliti, R., Cimini, A., & Benedetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215422 · Cited by 19
Lai, N., Fealy, C. E., Kummitha, C., Cabras, S., Kirwan, J. P., & Hoppel, C. L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00677 · Cited by 15
Kiani, P., Khodadadi, E. S., Nikdasti, A., Yarahmadi, S., Gheibi, M., Yousefi, Z., Ehtiati, S., Yahyazadeh, S., Shafiee, S. M., Taghizadeh, M., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05207-0 · Cited by 20
Broos, S., Windelinckx, A., Mars, G. D., Huygens, W., Peeters, M., Aerssens, J., VLIETINCK, R. F., Beunen, G. P., & Thomis, M. A. (2011) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2011.01406.x · Cited by 19
Molecular targets of exercise mimetics and their natural activators
Jang, Y. J., & Byun, S. (2021) · BMB Reports · doi:10.5483/bmbrep.2021.54.12.151 · Cited by 18
Zhou, Z., Ren, Q., Jiao, S., Cai, Z., Geng, X., Deng, L., Wang, B., Hu, L., Zhang, L., Yang, Y., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114061 · Cited by 16
Metabolic Functions of Peroxisome Proliferator-Activated Receptor β / δ in Skeletal Muscle
Gaudel, C., & Grimaldi, P. A. (2007) · PPAR Research · doi:10.1155/2007/86394 · Cited by 14
Phenylpropanoic acid derivatives bearing a benzothiazole ring as PPARδ-selective agonists
Fujieda, H., Usui, S., Suzuki, T., Nakagawa, H., Ogura, M., Makishima, M., & Miyata, N. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.05.017 · Cited by 15
Motoshima, K., Ishikawa, M., Hashimoto, Y., & Sugita, K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.03.065 · Cited by 15
Rubenstein, A. B., Smith, G. R., Zhang, Z., Chen, X., Chambers, T. L., Ruf-Zamojski, F. M., Mendelev, N., Cheng, W. S., Zamojski, M., Amper, M. A. S., et al. (2025) · Genome Research · doi:10.1101/gr.280051.124 · Cited by 15
Lund, M., Andersen, K. G., Heaton, R. A., Hargreaves, I. P., Gregersen, N., & Olsen, R. K. J. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166100 · Cited by 17
Ke, Q., Xiao, Y., Liu, D., Shi, C., Shen, R., Qin, S., Jiang, L., Yang, J., & Zhou, Y. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116076 · Cited by 16
Arrestins in Metabolic Regulation
Zhao, J., & Pei, G. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394440-5.00016-4 · Cited by 15
Yılmaz, H., Küçükhüseyin, Ö., Kurnaz, Ö., Akadam-Teker, B., Kurt, O., Tekeli, A., Öztürk, O., & İşbir, T. (2012) · DNA and Cell Biology · doi:10.1089/dna.2011.1464 · Cited by 18
Li, Z., Xu, Y., Cai, Z., Wang, X., Ren, Q., Zhou, Z., & Xie, R. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103803 · Cited by 14
Momordica Charantia: A Review of Its Effects on Metabolic Diseases and Mechanisms of Action
Cortez-Navarrete, M., Villar, M. M.-D., Ramos-González, E. J., & Pérez-Rubio, K. G. (2021) · Journal of Medicinal Food · doi:10.1089/jmf.2020.0206 · Cited by 15
Thermogenesis and Related Metabolic Targets in Anti-Diabetic Therapy
Arch, J. R. S. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_10 · Cited by 15
Ebert, B., Kisiela, M., & Maser, E. (2016) · Drug Metabolism Reviews · doi:10.3109/03602532.2016.1167902 · Cited by 15
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease
Cresci, S. (2008) · PPAR Research · doi:10.1155/2008/374549 · Cited by 15
Regulation of skeletal muscle PPARδ mRNA expression in twins
Nilsson, E., Poulsen, P., Sjögren, M., Ling, C., Ridderstråle, M., Groop, L., & Vaag, A. A. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.140673 · Cited by 15
Design of potent PPARα agonists
Sauerberg, P., Mogensen, J. P., Jeppesen, L., Bury, P. S., Fleckner, J., Olsen, G. S., Jeppesen, C. B., Wulff, E. M., Pihera, P., Havránek, M., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.015 · Cited by 14
Crosstalk between Lipids and Non-Alcoholic Fatty Liver Disease
Gowda, D., Shekhar, C., Gowda, S. G. B., Chen, Y., & Hui, S. (2023) · Livers · doi:10.3390/livers3040045 · Cited by 15
Thevis, M., Thomas, A., Kohler, M., Beuck, S., Möller, I., Schäfer, M., Rodchenkov, G. M., Yin, S. H., Loo, J. A., Geyer, H., et al. (2010) · European Journal of Mass Spectrometry · doi:10.1255/ejms.1047 · Cited by 15
Cho, S. Y., Jeong, H. W., Sohn, J. H., Seo, D.-B., Kim, W. G., & Lee, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033815 · Cited by 15
Lee, J. H., Jun, H., Jia, Y., Kim, W., Choi, S., & Lee, S. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf202910u · Cited by 13
Tachibana, K., Yuzuriha, T., Tabata, R., Fukuda, S., Maegawa, T., Takahashi, R., Tanimoto, K., Tsujino, H., Nunomura, K., Lin, B., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002077 · Cited by 13
Self-citationMouse models of nonalcoholic steatohepatitis and their application to new drug development
Phung, H. H., & Lee, C. H. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01410-5 · Cited by 13
The PPAR genes, cardiovascular disease and the emergence of PPAR pharmacogenetics
Cresci, S. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.15.2577 · Cited by 13
Adipose targets for obesity drug development
Boss, O., & Bergenhem, N. C. H. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.119 · Cited by 13
Jouzeau, J., Moulin, D., Koufany, M., Sébillaud, S., Bianchi, A., & Netter, P. (2008) · Journal de la Société de Biologie · doi:10.1051/jbio:2008034 · Cited by 15
Zhang, F., Sjöholm, Å., & Zhang, Q. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.103 · Cited by 14
Gellrich, L., & Merk, D. (2017) · Nuclear Receptor Research · doi:10.11131/2017/101310 · Cited by 15
Dietary regulation of peroxisome proliferator-activated receptors in metabolic syndrome
Zou, H., Gong, Y., Ye, H., Yuan, C., Li, T., Zhang, J., & Ren, L. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154904 · Cited by 15
Metabolic switching of human skeletal muscle cells in vitro
Thoresen, G. H., Hessvik, N. P., Bakke, S. S., Aas, V., & Rustan, A. C. (2011) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2011.04.017 · Cited by 25
Gim, H. J., Li, H., Jeong, J. H., Lee, S. J., Sung, M., Song, M., Park, B., Oh, S. J., Ryu, J., & Jeon, R. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.046 · Cited by 12
Debard, C., Cozzone, D., Ricard, N., Vouillarmet, J., Disse, E., Husson, B., Laville, M., & Vidal, H. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0077-x · Cited by 13
Emerging Therapies for Nonalcoholic Fatty Liver Disease
Hameed, B., & Terrault, N. A. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2015.10.015 · Cited by 12
Metadata
- Authors
- Tanaka, T., Yamamoto, J., Iwasaki, S., Asaba, H., Hamura, H., Ikeda, Y., Watanabe, M., Magoori, K., Ioka, R. X., Tachibana, K., Watanabe, Y., Uchiyama, Y., Sumi, K., Iguchi, H., Ito, S., Doi, T., Hamakubo, T., Naito, M., Auwerx, J., Yanagisawa, M., Kodama, T., & Sakai, J.
- Affiliations
- Tohoku University (JP)
- Laboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan; Pharmacology II, Department of Research and Development, Grelan Pharmaceutical Co. Ltd., Tokyo 205-8501, Japan; Division of Nephrology, Endocrinology, and Vascular Medicine, Department of Medicine, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan; Yanagisawa Orphan Receptor Project, Exploratory Research for Advanced Technology, Japan...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2003-12-15
- Volume
- 100
- Issue
- 26
- Pages
- 15924-15929
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC307669
- OpenAlex
- W1982027543
- Cited by
- 832
- References
- 18
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 16 · 2023: 16 · 2022: 21 · 2021: 32 · 2020: 36 · 2019: 13 · 2018: 42 · 2017: 28 · 2016: 25 · 2015: 33 · 2014: 36 · 2013: 35 · 2012: 39
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- PPARδ, fatty acid beta-oxidation, skeletal muscle, metabolic syndrome, GW501516, insulin resistance, obesity, high-fat diet, mitochondrial respiration, fatty acid uptake, lipid droplets, diabetes mellitus, ob/ob mice, metabolic rate
- MeSH terms
- Animals, Dimethyl Sulfoxide, Enzymes, Fatty Acids, Nonesterified, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Oxidation-Reduction, Thiazoles, Transcription Factors, Receptors, Cytoplasmic and Nuclear, Muscle, Skeletal, Metabolic Syndrome, Lipid Metabolism, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.